Non-transitional cell bladder carcinomas

BJU Int. 2005 Mar;95(4):497-502. doi: 10.1111/j.1464-410X.2005.05327.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Adenocarcinoma* / epidemiology
  • Adenocarcinoma* / pathology
  • Adenocarcinoma* / therapy
  • Antineoplastic Agents, Alkylating / therapeutic use
  • Carcinoma, Squamous Cell* / epidemiology
  • Carcinoma, Squamous Cell* / pathology
  • Carcinoma, Squamous Cell* / therapy
  • Cyclophosphamide / therapeutic use
  • Cystectomy / methods
  • Humans
  • Male
  • Neoplasm Recurrence, Local
  • Prognosis
  • Risk Factors
  • Schistosomiasis haematobia / complications
  • Urinary Bladder Neoplasms* / epidemiology
  • Urinary Bladder Neoplasms* / pathology
  • Urinary Bladder Neoplasms* / therapy

Substances

  • Antineoplastic Agents, Alkylating
  • Cyclophosphamide